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Olfactory bulb (OB) neurogenesis generates neurons that use GABA or dopamine as their
neurotransmitters throughout life. Regionalized stem cell populations in the periventricular
zone (PVZ) of the lateral ventricles (LVs) have been shown to be at the basis of neuronal
diversity in the system. For example dopaminergic neurons arise predominantly from
neural stem cells (NSCs) residing in the dorsal PVZ and depend on the expression
of the transcription factors Pax6 and Dlx2 for their specification. In addition, Dlx2 is
required for neurogenesis in general. Using targeted in vivo electroporation combined
with immuno-fluorescence imaging and microarray analysis, we provide here detailed
spatial and temporal expression data with cellular resolution in this system. We find
that all along the neurogenic process Pax6 expression remains restricted to the dorsal
PVZ, whereas nearly all neuroblasts express Dlx2, including those of the dorsal lineage,
which are switched on for Dlx2 when they enter the rostral migratory stream (RMS).
These data allow to explain and precise the functions of these two genes in postnatal
OB neurogenesis.
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INTRODUCTION
Neurogenesis persists in the postnatal and adult mouse olfac-
tory bulb (OB). In this system, neuroblasts are generated in the
periventricular zone (PVZ) of the lateral ventricles (LVs). After
a phase of amplification they migrate along the rostral migra-
tory stream (RMS) to differentiate into OB interneurons that
play a major role in olfactory function (Lledo et al., 2006). The
newly generated interneurons in the OB present a large diversity
of phenotypes. For example, the superficial region of the OB con-
tains many dopaminergic neurons whereas neurons located in the
deeper layers are purely GABAergic (Alvarez-Buylla and Garcia-
Verdugo, 2002; Lledo et al., 2008). It has been shown that this
phenotypic diversity relies on the spatial distribution of the corre-
sponding neural stem cells (NSCs) in the germinal zone, the PVZ
(Merkle et al., 2007). The molecular determinants of this mosaic
organization in the SVZ are still poorly understood and only start
to be investigated. For example, it has been recently shown that
Shh signaling in the most ventral part of PVZ controls differenti-
ation of a particular OB neuronal subtype that is characterized by
calbindin expression (Ihrie et al., 2011).
Dopaminergic neurons of the OB represent a population of
particular interest for cell replacement strategies in Parkinson’s
disease as their precursors could be an alternative source for
neurons for transplantation or recruitment to lesion sites (Lie
et al., 2004). Lineage analyses showed that these dopaminergic
neurons mostly originate from the dorsal PVZ. At the molecular
level, several transcription factors were shown to be required for
proper differentiation of these dopaminergic neurons, namely
Pax6, Dlx2, Id2, Klf7, and ER81 (Hack et al., 2005; Kohwi et al.,
2005; Saino-Saito et al., 2007; Brill et al., 2008; Havrda et al., 2008;
Caiazzo et al., 2011). Among these factors, Pax6 and Dlx2 seem to
play a major role as their overexpression was able to increase the
generation of this type of neurons (Hack et al., 2005; Kohwi et al.,
2005; Brill et al., 2008). However, additional expression and func-
tional data draw amore complex situation that hardly fits with the
specific involvement of these two TFs in the specification of the
dopaminergic phenotype in the OB. Indeed, it has been suggested
that Pax6 is not confined to the dorsal PVZ, but widely expressed
in most RMS neuronal precursors where it is required for induc-
tion of neuronal commitment in general (Hack et al., 2005). In
contrast, Dlx2 mRNA expression seems to be restricted to the lat-
eral PVZ (Brill et al., 2008), which is in contradiction with the
dorsal origin of OB dopaminergic neurons (Merkle et al., 2007).
Here we provide detailed and dynamic expression data that
offer a more detailed picture and reconcile these discrepancies.
First, we show that Pax6 protein expression is not distributed
as widely as expected, but merely restricted to the dorsal lin-
eage from the PVZ stem cells to the mature neurons of the OB.
Second, we show that while Dlx2 is initially restricted to lateral
progenitors, its expression is at later time points also induced in
descendants of the dorsal PVZ, thus, explaining how Dlx2 can
regulate dopaminergic fate in this system.
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MATERIALS AND METHODS
ANIMALS
All animals were treated according to protocols approved by
the French Ethical Committee. CD1 mice (Charles River, Lyon,
France) were used for in vivo electroporation and expression
pattern analyses.
FOREBRAIN ELECTROPORATION
P1 pups were electroporated as described in (Boutin et al., 2008).
2μl of a pCAGGS-eGFP plasmid solution at a concentration of
5μg/μl in PBS was injected into the brain LV. Electroporation was
performed using the CUY21 edit device and the 10mm tweezers
electrodes (CUY650P10) (Nepagene, Chiba, Japan) coated with
conductive gel (Signagel, Parker Laboratories, USA). Electrodes
were distinctly positioned in order to target either the lateral or
the dorsal wall of the ventricle.
IMMUNOHISTOCHEMISTRY AND IMAGE ANALYSES
Immunohistochemistry was performed on free-floating sections
as described previously (Boutin et al., 2010). Optical images were
taken using a fluorescence microscope (Axiolmager Z1, ApoTome
system, Zeiss, Germany) or a laser confocal scanning microscope
(LSM510, Zeiss, Germany).
Primary antibodies: anti-Pax6 (mouse from Millipore, 1:700;
rabbit from Covance, 1:400), the anti-Dlx2 was provided by Prof.
Yoshikawa. Secondary antibodies include anti-rabbit HRP con-
jugated (Jackson ImmunoResearch Laboratories), anti-mouse,
anti-rabbit and anti-chicken Alexa 555 conjugated (Invitrogen).
All images were analyzed blind to the experimental condition.
Data are presented as mean ± SEM. Unless otherwise specified, n
represents the number of animals analyzed. Two-tailed unpaired
Student’s t-test was used to assess differences between data groups
using Instat software (Graph Pad Software). Differences were
considered statistically significant when P < 0.05.
MICROARRAY ANALYSIS
For sorting GFP fluorescent cells, pups are sacrificed at different
times after in vivo electroporation and brain tissue from which
cells have to be sorted are dissected under the microscope. Cells
are dissociated as described before (Seidenfaden et al., 2006)
and fluorescent cells were sorted using a MoFlo flow cytometry
sorter (Beckman Coulter). RNA was extracted, amplified using
the SuperAmp Technology (Miltenyi), and hybridized (two col-
ors protocol, each color corresponding to a targeted region, dorsal
or lateral wall) on a G4122F Whole Mouse Genome (4 × 44 K)
OligoMicroarrays (Agilent) as described previously (Boutin et al.,
2010). Results were processed as described previously (Boutin
et al., 2010). For conditions 2 (8 hpe and 2 dpe) or 3 (1, 4, 7,
14 dpe) independent repetitions were performed and data are
presented as mean ± SEM of normalized intensity values.
RESULTS
Pax6 PROTEIN EXHIBITS A DORSAL EXPRESSION IN THE PVZ
Immunohistochemistry showed that most of the PVZ cells
expressing Pax6 are located in the dorsal wall of the ventricle
(Figure 1A). In the lateral wall Pax6 expression exhibits a dorso-
ventral descending gradient leading to the total absence of Pax6
detection in the most ventral part of the PVZ (Figure 1A). To
analyze the time course and extent of Pax6 expression in the dor-
sal PVZ we used in vivo electroporation. This technique presents
two main advantages. First, it allows the specific transfection of
radial glia (Doetsch et al., 1999; Boutin et al., 2008, 2010), the pri-
mary NSCs in the system. Second, it is possible to target specific
PVZ regions, such as dorsal vs. lateral walls, through the orienta-
tion of the electrical field applied to the mouse head (Fernandez
et al., 2011) (Figure 1B). Therefore, this technique allows dis-
criminating dorsally vs. laterally generated cells in the RMS and
OB, although these cells are intermingled in both structures.
We used expression of GFP to label cohorts of cells in the
system and isolate these cohorts at different time points. It
has been shown that 6 hours post-electroporation (hpe) of a
GFP-expressing plasmid in the PVZ green cells are radial glial
NSCs, while at 2 days post-electroporation (dpe) they are a mix
of NSCs, transit-amplifying precursors and neuroblasts (Boutin
et al., 2008). At 4 dpe in RMS the GFP+ cells are migrating neu-
roblasts and at 15 dpe in the OB they are differentiating neurons
(Boutin et al., 2008, 2010).
When electroporated the dorsal wall of P1 mice we observed
that at 6 hpe more than 80% of the electroporated radial glial cells
expressed Pax6 endogenously (Figures 1C,E). The ratio remained
similar two days later in transit-amplifying and neuroblast pre-
cursors (80 ± 5% Pax6+/GFP+ cells; Figures 1D,E). In contrast,
the percentage of GFP+ cells expressing Pax6 dropped to around
20% in a region comprising 100μm of the most dorsal part
of the lateral PVZ (the horn in Figure 1A) and became almost
null in the most ventral PVZ (3 ± 1% Pax6+/GFP+ cells in lat-
eral PVZ; Figures 1C–E) at both time points (n = 3 animals per
group, more than 200 cells per group, ∗p < 0.05, ∗∗p < 0.01).
These results, showing a restriction of Pax6 protein to the dorsal
PVZ, are in perfect agreement with a specific involvement of Pax6
in dopaminergic fate determination. The fact that the primary
NSCs already differentially express Pax6 in a dorso-lateral gra-
dient suggests that this determination occurs precociously in the
immature NSCs.
Pax6 EXPRESSION IN NEUROBLASTS AND DIFFERENTIATED NEURONS
IS PREFERENTIALLY FOUND IN THE DORSAL PVZ LINEAGE
Several previous data suggested a requirement of Pax6 for gen-
eral OB neurogenesis (Hack et al., 2004, 2005; Jang and Goldman,
2011). This statement does not fit with our data showing a restric-
tion of Pax6 expression in the dorsal aspect of the PVZ but might
be based on an expression in the lateral lineage at later time points
in the RMS or OB. We thus investigated Pax6 expression in the
lateral lineage in comparison to the dorsal lineage to determine
whether Pax6 expression is activated in lateral descendents at
later differentiation stages, i.e., at 4 dpe in the RMS and at 15 dpe
in the OB.
Observation of electroporated cells at 4 dpe confirmed that
migrating RMS neuroblasts are intermingled (Figure 2A). In the
OB at 15 dpe, dorsally electroporated cells were mostly superficial
granule and periglomerular neurons while laterally electropo-
rated cells colonized the deep layers of the granule cell layer (GCL)
(Figure 2B). Four dpe, the percentage of GFP+ cells expressing
Pax6 in the RMS remained significantly higher in the dorsal
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FIGURE 1 | Pax6 expression is restricted dorsally in the periventricular
region. (A) Low magnification view of a coronal section of the P1 forebrain
labeled with Pax6 antibody (red). The signal is strong and widespread in the
dorsal periventricular zone (dPVZ), weaker at the junction between the dorsal
and lateral walls (horn and yellow) and faint and rare in the lateral wall (lPVZ).
(B) PVZ coronal section 6 h after a dorsal (top) or a lateral (bottom)
electroporation with a GFP expressing plasmid. Pax6 is labeled in red.
(C and D) Pax6 expression (red) by GFP-expressing cells after GFP
electroporation in the dorsal (upper panel) or lateral wall (lower panel).
At 6 hpe (C), radial glial neural stem cells express Pax6 in the dorsal,
but not lateral, PVZ. (D) Similarly, most amplifying precursors and
neuroblasts of the dorsal but not lateral PVZ express Pax6 (arrowheads:
GFP+/Pax6+ cells, arrows: GFP+/Pax6− cells). (E) Histograms depicting in
three regions of the PVZ (dorsal PVZ, horn, and lateral PVZ) the percentage
of GFP electroporated cells co-expressing Pax6 6h or 2 h days after dorsal
or lateral electroporation (n = 3 animals per group, more than 200 cells
per group, ∗p < 0.05, ∗∗p < 0.01). LV: lateral ventricle. Scale bars:
20μm.
than in the lateral lineage (49 ± 8% vs. 11 ± 1% Pax6+/GFP+
cells, respectively; n = 3–5 mice, more than 100 cells per group,
p < 0.05) (Figures 2C,D). At 15 dpe, we determined the ratio of
GFP+ cells expressing Pax6 in the granule cell and the glomeru-
lar layers (GCL and GL, respectively), the two target layers of OB
neurogenesis. In both dorsal and lateral electroporations, the pro-
portion of GFP+ cells expressing Pax6 was significantly higher
in the GL than in the GCL. This was in accordance with the
role of Pax6 in the determination of dopaminergic neurons that
are confined to the GL. Importantly, we again observed a strong
preferential expression of Pax6 in cells issued from the dorsal
PVZ in both GCL and GL (48 ± 5% vs. 17 ± 2% Pax6+/GFP+
cells in GCL and 97 ± 2% vs. 56 ± 5% Pax6+/GFP+ cells in GL;
Figures 2C,D).
Altogether these data show that, in accordance with its
role in dopaminergic fate determination, Pax6 expression is
preferentially expressed in the entire dorsal lineage throughout
the neurogenic process.
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FIGURE 2 | Pax6 remains preferentially expressed in the dorsal lineage in
neuroblasts migrating in the RMS and in new neurons of the olfactory
bulb. (A and B) Distribution of dorsally or laterally generated GFP+ cells in
the RMS at 4 dpe (A) and in the olfactory bulb at 15 dpe (gl: glomerular
layer, epl: external plexiform layer, sl: superficial layer of the granule cell
layer, dl: deep layer of the granule cell layer) (B). (C) 3-D reconstructions of
merged images of dorsally (upper panel) or laterally (lower panel)
electroporated GFP+ cells (green) labeled with Pax6 antibody (red)
at 4 or 15 dpe. These images show that dorsally but not laterally generated
GFP+ cells in the RMS and in the granule cell layer (GCL) or glomerular layer
(GL) of the OB express Pax6. (D) Histograms representing the percentage of
GFP electroporated cells expressing Pax6 4 days after electroporation in the
RMS and 15 days after electroporation either in the GCL or in the GL, after
dorsal (dark gray bars) or lateral (light gray bars) electroporation
(n = 3–5 mice per group). Scale bars: A, 50μm; B, 200μm;
C, 20μm.
Dlx2 EXPRESSION IS EXCLUSIVE TO THE LATERAL PVZ BUT IS
ACTIVATED IN ALL RMS NEUROBLASTS
A function for Dlx2 in dopaminergic subtype specification during
OB neurogenesis has been proposed (Brill et al., 2008). However,
in situ hybridization data showed mRNA expression only in the
lateral PVZ (Brill et al., 2008), which is in disagreement with a role
of Dlx2 in the dopaminergic fate specification, since dopamin-
ergic neurons arise mostly from the dorsal PVZ (Merkle et al.,
2007).We thus revisited the expression of Dlx2 in the entire dorsal
and lateral lineages by immunohistochemistry.
In PVZ, we detected Dlx2 protein almost exclusively in the
lateral aspect, confirming the available in situ hybridization data
(Brill et al., 2008) (Figure 3A). We then electroporated a GFP
plasmid in the lateral and dorsal PVZ and searched for Dlx2
expression in the electroporated cells. We observed that 6 hpe
all fluorescent radial glia cells were Dlx2 negative (Figures 3B,C,
and 4E). However, Dlx2 protein was expressed in most GFP+
transit-amplifying cells and neuroblasts derived from lateral
radial glia two days after electroporation (93 ± 1%; Figures 3E
and 4E). In contrast, barely any dorsally electroporated radial
glia or immediate PVZ descendants expressed Dlx2 (2 ± 1%;
Figures 3B,D, and 4E; n = 3–5 mice, more than 100 cells per
group; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001) despite the
occasional occurrence of other cells that expressed Dlx2 at low
level (Figures 3B,D). These results show that in the PVZ, Dlx2 is
restricted to lateral transit-amplifying cells and neuroblasts and
that Pax6 and Dlx2 expressions are not overlapping in PVZ stem
cells and early progenitors.
Then, we investigated the time course of Dlx2 expression at
later stages to determine whether Dlx2 expression is induced later
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FIGURE 3 | Dlx2 expression in the PVZ is restricted to the
non-radial glial progenitor cells of the lateral wall. (A) Low
magnification of a P1 mouse brain coronal section labeled with Pax6
(red) and Dlx2 (blue) antibodies showing an overall complementary,
non-overlapping expression of these two genes in the PVZ. (B–E) High
magnification of dorsally or laterally GFP electroporated cells labeled with
Pax6 and Dlx2 antibodies at 6 h (B,C) and two days (D,E) after
electroporation. Note that the dorsally electroporated cells expressed
Pax6 but not Dlx2 (B,D). As expected the laterally electroporated cells
did not express Pax6 at any time. The lateral radial glial neural stem cells
did not express Dlx2 at 6 hpe (C), while the transit-amplifying and
neuroblast progeny did express Dlx2 at 2 dpe (E). Arrowheads:
GFP+/marker+ cells, arrows: GFP+/marker− cells. Scale
bar: 10μm.
in the dorsal-derived population. We first electroporated a GFP
plasmid either dorsally or laterally in the PVZ and then isolated
GFP+ cells by Fluorescent Activated Cell Sorting (FACS) at differ-
ent time points. Genome-wide transcriptomic microarrays were
then performed on amplified material from sorted cells. At 8 hpe,
a stage at which the sorted cells were predominantly radial glia,
Dlx2 intensity values were low in all samples. In contrast, at 1
and 2 dpe Dlx2 expression was significantly increased in the lat-
eral samples but remained low in the dorsal fraction (Figure 4A).
These results are in full agreement with our immunohistochem-
ical analyses (Figures 3B–E). Interestingly, we observed an acti-
vation of Dlx2 expression at 4, 7, and 14 dpe in the dorsally
electroporated cells, in both RMS and OB. Meanwhile, Dlx2
expression was maintained high in the laterally electroporated
cells (Figure 4A).
To further confirm these data we performed immunohisto-
chemical analyses on GFP electroporated cells at 4 and 15 dpe
using Dlx2 and Pax6 antibodies. The results confirmed the
microarray data, showing that in contrast to 6 hpe and 2 dpe the
majority of dorsally electroporated RMS neuroblasts andOB neu-
rons induced Dlx2 expression in addition to Pax6 at 4 and 15 dpe,
respectively, (96 ± 1% Dlx2+/GFP+ cells in RMS vs. 97 ± 3% in
OB, Figures 4B–D). As expected, most laterally electroporated
cells remained Dlx2+ at these time points (90 ± 3%Dlx2+/GFP+
cells in RMS vs. 98 ± 2% in OB; Figures 4E and 5).
In conclusion, this demonstrates that while lateral cells are
Dlx2-positive from early time points in the PVZ, dorsally derived
neuroblasts induce Dlx2 at later time points, during their journey
to the OB.
DISCUSSION
Cell replacement for the treatment of neurodegenerative diseases
may be achieved either by grafting neurons or by mobilizing
ongoing postnatal neurogenesis (Lie et al., 2004). In this view,
OB neurogenesis presents some evident advantages, especially
in the context of Parkinson’s disease as it generates dopaminer-
gic neurons that survive this condition (Hoglinger et al., 2004;
Winner et al., 2006). OB neurogenesis may be a natural source
for neuronal replacement that could circumvent the ethical, pro-
visioning, and immune rejection problems brought by trans-
plantations (Isacson, 2003). Furthermore, from a fundamental
point of view, OB neurogenesis is a very amenable system that
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FIGURE 4 | Dlx2 gets activated in the dorsal lineage once cells have
entered the RMS and is maintained in the OB. (A) Evolution of Dlx2
transcript expression over time in the dorsal (red) and lateral (blue)
lineages obtained from microarray analysis performed on FAC-sorted GFP
electroporated cells at successive time points. (B–D) High
magnifications of dorsally generated GFP+ cells labeled with Pax6 (red) and
Dlx2 (blue) antibodies in the RMS at 4 dpe (B), or in the granule cell
layer (C) and glomerular layer (D) at 15 dpe. Arrowheads:
GFP+/marker+ cells. Note that both in the RMS and the GCL and
GL of the OB Dlx2 is co-expressed with Pax6 in dorsally generated GFP
electroporated cells. (E) Evolution of Dlx2 expression in dorsal (red) or
lateral (blue) GFP+ electroporated cells at successive time after
electroporation (n = 3 mice per group). Scale bar:
10μm.
allows studying the control of neurogenesis in general and also the
molecular basis of neuronal diversity. The system is of particularly
suited to investigate how the dopaminergic fate in the forebrain is
determined.
Previous work has established the transcription factors Pax6
and Dlx2 as regulators of the dopaminergic specification dur-
ing postnatal OB neurogenesis, together with few other factors
(Havrda et al., 2008). Pax6 appears to play a major role in this
specification as Pax6 mutant PVZ precursors grafted to a host
PVZ are able to generate OB neurons except for the dopamin-
ergic subtype (Kohwi et al., 2005). Furthermore, overexpression
or inhibition of Pax6 by retroviral injections in vivo increases and
reduces the proportion of OB dopaminergic neurons in the OB,
respectively (Hack et al., 2005). The function of Dlx2 in the sys-
tem is less specific as lack of Dlx2 interferes with neuron produc-
tion in general (Qiu et al., 1995). Nevertheless, Dlx2 can induce
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FIGURE 5 | The lateral PVZ lineage remains positive for Dlx2 in
neuroblasts and mature neurons. High magnification of laterally
electroporated GFP+ cells labeled with Pax6 (red) and Dlx2 (blue) antibodies
at 4 or 15 days after electroporation. Note that both in the RMS at 4 dpe and
in the GCL and GL of the OB at 15 dpe cells are negative for Pax6 as
expected and remain positive for Dlx2.
the dopaminergic fate in this system because its overexpression in
the PVZ increases the genesis of OB dopaminergic neurons (Brill
et al., 2008).
Surprisingly these functional analyses were not fully supported
by several expression data. Indeed, Pax6 expression studies indi-
cated that most, if not all, neuroblasts express Pax6 in the RMS
(Hack et al., 2005). This, plus the fact that Pax6 induces neurons
in neurosphere cells that otherwise generate predominantly glia
(Hack et al., 2004) lead these authors to postulate that Pax6 is a
general neurogenic factor for OB neurogenesis (Hack et al., 2005).
We show here, using a technique allowing neuronal lineage
tracing at both the regional and cellular levels that Pax6 is in
fact highly enriched in the dorsally generated cells, from the stem
cell in PVZ to the differentiated neuron in the OB. Pax6 is only
very rarely found in a laterally generated cell. This high reso-
lution expression analyses show that Pax6 is not required for
lineage progression of laterally generated cells, indicating that the
transcription factor does not act as a general neurogenic factor.
Instead, a major role of Pax6 in this system appears to be the
determination of the dopaminergic neurotransmitter phenotype
in the GL (Hack et al., 2005; Kohwi et al., 2005). However, the
existence of a substantial proportion of GCL neurons express-
ing Pax6 (Figure 2D) suggests additional roles for Pax6 in OB
neurogenesis.
Another paradox concerns the apparent discrepancy between
Dlx2 expression and its role in dopaminergic specification.
Indeed, Dlx2 mRNA appears restricted to the lateral PVZ (Brill
et al., 2008) whereas dopaminergic neurons are generated by
dorsal PVZ (Merkle et al., 2007). Using in vivo electroporation,
dynamic microarray analyses, and immunohistochemistry, we
show that Dlx2 expression in dorsally generated cells is switched
on in RMS neuroblasts and maintained in the OB. These data
fit with the functional data stating a dual role of Dlx2 in the
neurogenesis in general and a more specific involvement in the
dopaminergic fate specification (Brill et al., 2008). Dlx2 expres-
sion is temporally regulated in the process. Indeed, at the PVZ
transit-amplifying cells stage Dlx2 is confined to the lateral lin-
eage but absent from dorsal cells. However, once in the RMS as the
transcription factor is induced in migrating neuroblasts of both
lineages. Whether this complex regulation of expression timing
has functional significance needs to be investigated.
In conclusion, we present here dynamic expression data for
two genes showing a regionalized expression in the PVZ. This
regionalized expression for Pax6 reveals a specific and permanent
involvement in dopaminergic fate determination. For Dlx2 how-
ever, this regionalized expression is transient in accordance with
the more general role of this gene in neurogenesis. We believe
that our study highlights the necessity, when studying molecular
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determinants of fate specification, to follow their expression in
a dynamic fashion as performed in our comparative genomic
screen on dorsally vs. laterally electroporated cells at different
times after electroporation of the primary stem cells. Extending
this analysis to the whole genome will draw a detailed spatial
and temporal expression map of important genes in postnatal
OB neurogenesis. Similarly to what we describe here for Pax6 and
Dlx2 this map might allow us to validate, reject or even identify
new molecular determinants for neuronal subtype specification
in the postnatal brain.
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